Clinical Trials in Austin

Showing 3201-3220 of 7,312 trials

Evaluation of QDOT MICRO™ Catheter for Pulmonary Vein Isolation in Subjects With Paroxysmal Atrial Fibrillation

NCT03775512

Prospective, non-randomized, pre-market clinical evaluation of the QDOT MICRO™ Catheter to demonstrate the safety and effectiveness when compared to an historical control performance goal.

Paroxysmal Atrial Fibrillation

Biosense Webster, Inc.283 participantsStarted Jan 2019

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Atlantis, Florida, United States +19 more locations

TERMINATEDPhase 2< 1 mile

A Study to Test if TEV-48574 is Effective in Relieving Asthma

NCT04545385

The primary objective of the study is to evaluate the effect of TEV-48574 compared with placebo on loss of asthma control (LoAC) in adult participants with T2-low and non-T2 severe asthma uncontrolled on inhaled corticosteroids plus long-acting beta-agonists (ICS+LABA). The secondary efficacy objective is to evaluate the effect of TEV-48574 compared with placebo on a range of clinical measures of asthma control. The duration of participant participation in the study is planned to be up to approximately 30 weeks.

Asthma

Teva Branded Pharmaceutical Products R&D, Inc.65 participantsStarted Oct 2020

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Bakersfield, California, United States +94 more locations

Evaluation of QDOT MICRO™ Catheter for Pulmonary Vein Isolation in Subjects With Paroxysmal Atrial Fibrillation

A Study to Test if TEV-48574 is Effective in Relieving Asthma

Find Trials by Condition in Austin

AMBULATE Continued Access Protocol to Evaluate the Cardiva Mid-Bore Venous Vascular Closure System (VVCS)

OPTIMIZE IDE for the Treatment of ACS

Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance

A Study of TDM-105795 in Male Subjects With Androgenetic Alopecia (AGA)

Phase 1 Study of RBN-2397, an Oral PARP7 Inhibitor, in Patients With Solid Tumors

Tomivosertib (eFT-508) in Combination With PD-1/PD-L1 Inhibitor Therapy

(EXPLORER) Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid Malignancies

Neoadjuvant Carboplatin and Vincristine and Standard Local Ophthalmic Therapy in Treating Patients With Intraocular Retinoblastoma

Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With Schizophrenia

Effects of Oral Levosimendan on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis (ALS): Open-Label Extension

A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures

Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity

Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19

FREEDOM COVID-19 Anticoagulation Strategy

A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease

Assessment of Safety and Efficacy of Nerivio for the Migraine Prevention

A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110]

The TREFOIL Concept 5 Year Clinical Investigation